Core Laboratories N.V. Overcomes a String of Hurricanes to Post Expectation-Beating Results
Up until last quarter, the greatest headwind facing Core Laboratories (NYSE: CLB) was the steep decline in oil prices, which negatively affected oil-field activities. While the fierceness of that headwind has started to abate, a more literal one emerged in the third quarter in the form of hurricanes, which disrupted business activity in the oil patch. That said, the impact wasn't as bad as Core initially feared, enabling the company to deliver above-guidance results.
Metric
Q3 2017
Source: Fool.com
Core Laboratories Inc. Aktie
15,00 €
0,67 %
Leichtes Sell-Übergewicht bei Core Laboratories Inc. mit 3 Sell- gegenüber 0 Buy-Einschätzungen.
Ein negatives, wenn auch nicht starkes, Potenzial für Core Laboratories Inc. mit einem Kursziel von 14 € im Vergleich zu 15.0 €.
